Bellicum Pharma (BLCM) Reports Q3 Loss Per Share of $0.51

Bellicum Pharma (NASDAQ: BLCM) reported Q3 EPS of ($0.51), versus $2.08 reported last year.

For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• SanDisk upgraded at JPMorgan after investor day; shares climb